Taipei, Taiwan

Shih-Hsiung Wu

USPTO Granted Patents = 10 


Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 1998-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Shih-Hsiung Wu

Introduction

Shih-Hsiung Wu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical diagnostics and vaccine development. With a total of 10 patents to his name, his work has had a profound impact on healthcare.

Latest Patents

One of his latest patents involves diagnostic kits and methods designed to rapidly and non-invasively determine physiologic levels of galactose-deficient IgA1 (Gd-IgA1) in subjects suffering from IgA nephropathy. This invention provides a lectin as diagnostic reagents for IgA nephropathy and includes a diagnostic kit for detecting Gd-IgA1, utilizing RussiaSea-001 and RussiaSea-002. Another notable patent is related to glycoconjugate vaccines, which confer protection against Gram-negative pathogen infections. This patent outlines a method for manufacturing the glycoconjugate vaccine and its use in treating bacterial infections.

Career Highlights

Shih-Hsiung Wu has worked with esteemed organizations such as the Institute of Occupational Safety and Health Council of Labor Affairs and Academia Sinica. His career reflects a commitment to advancing medical science and improving public health through innovative solutions.

Collaborations

Throughout his career, Wu has collaborated with notable colleagues, including Chung-Yun Gau and Chi-Fu Tai. These partnerships have contributed to the success of his research and inventions.

Conclusion

Shih-Hsiung Wu's contributions to medical diagnostics and vaccine development highlight his role as an influential inventor. His innovative patents continue to pave the way for advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…